Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

28246711066_52e38bc591_z

No-deal Brexit could cause shortages and higher prices, healthcare distributors warn

June 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, distribution, pharma, supply chain

The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …
News

NICE recommends Amgen’s Blincyto in rare acute lymphoblastic leukaemia sub-population

June 19, 2019 Research and Development, Sales and Marketing Amgen, Cancer, NICE, acute lymphoblastic leukaemia, blincyto, pharma

Patients on the NHS in England and Wales will now be able to access Amgen’s Blincyto (blinatumomab) after NICE reveals …
News

Contract manufacturing services industry set to grow at CAGR of 10.6% between 2017-2027

June 19, 2019 Research and Development EU, Europe, biopharma, contract manufacturing services, manufacturing, pharma

The biopharmaceutical contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 10.6% between 2017 …
News
merck-keytruda

MSD’s Keytruda snatches up first approval in small cell lung cancer

June 19, 2019 Research and Development, Sales and Marketing Cancer, FDA, MSD, US, keytruda, lung cancer, pharma

MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …
News
european_commission_web_5

EU pharmaceutical industry lost €16.5 billion in sales as staff shift to patent infringing firms

June 19, 2019 Research and Development EU, counterfeit, generics, pharma, sales

A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 …
News
16792957331_d9572dbdf4_z

FDA expand Paragraph IV Patent Certifications List for generic drugmakers

June 19, 2019 Research and Development FDA, Hatch-Waxman act, generic drugs, generics, pharma

The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …
News
millerblockchainadj-1600x1200

The missing link: Blockchain in clinical data management

June 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, blockchain, data, data management, pharma, supply chain

Louis Goss explores the potential uses for the much-hyped technology blockchain as a tool to tackle the data management challenges …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

June 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, GSK, J&J, JJ, Otsuka, Pfizer, Purdue, Sanofi, Vertex, pharma

Pfizer supressed research showing their arthritis drug Enbrel reduced the risk of Alzheimer’s. This was the big revelation this week! …
News
dr_aiden_cottrell

GSK tech exec joins Institute of Cancer Research

June 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Institute of Cancer Research (ICR) has said GlaxoSmithKline’s Dr Adrian Cottrell will join as the institute’s new Chief Information …
Appointment
genentech_web

FDA offer priority review for Genentech’s Rituxan in children

June 13, 2019 Research and Development

The FDA will offer priority review to Genentech’s supplemental biologics-license application (sBLA) application for Rituxan for children with two rare …
News
sobi_offices

Sobi acquire Novimmune in deal worth more than £400 million

June 13, 2019 Business Services, Research and Development R&D, emapalumab, immuno-oncology, immunology, pharma

Swedish rare disease specialist Sobi has agreed to buy Swiss firm Novimmune ion a deal worth more than £400 million. …
News
cq5dam

AstraZeneca spends more than twice as much as expected on new HQ

June 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, UK, headquarters, pascal soriot, pharma

AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that …
News

Fewer opioids prescribed in states with medical marijuana, research shows

June 12, 2019 Research and Development Marijuana, medicinal cannabis, opioids, pharma

Fewer opioids are prescribed in states with legal medical marijuana, according to research from University of Texas Medical Branch at …
News

J&J ‘worse’ than Purdue Pharma expert witness says

June 12, 2019 Research and Development J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, phamra

The role Johnson & Johnson played in the opioid crisis was ‘in some ways worse’ than that of Purdue Pharma, …
News

Novo Nordisk’s oral diabetes drug safe and effective

June 12, 2019 Research and Development GLP-1, Novo Nordisk, diabetes, pharma, samgalutide

Novo Nordisk’s oral diabetes drug semaglutide is safe for those at high risk of cardiovascular complications, according to the results …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026